Presentation Information
[AO-01-1]A centrally-acting BTK inhibitor improves aggressive MSA-C by suppressing proinflammatory microglia
Yuu-ichi Kira1, Masaki Katsuhisa1, Masaya Harada1,2, Dai Matsuse1, Hiroo Yamaguchi1,3, Tatsunori Tanaka1,4, Kei Fujishima1, Ryo Yamasaki1, Noriko Isobe1, Jun-ichi Kira5,6 (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan, 3.School of Physical Therapy, Faculty of Rehabilitation, Reiwa Health Science University, Japan, 4.Sumitomo Pharma Co., Ltd., Japan, 5.Translational Neuroscience Research Center, Graduate School of Medicine, and School of Pharmacy at Fukuoka, International University of Health and Welfare, Japan, 6.Department of Neurology, Brain and Nerve Center, Fukuoka Central Hospital, Japan)